We are live on ! Find out more
ASND icon

Ascendis Pharma A/S
ASND

36 hedge funds and large institutions have $146M invested in Ascendis Pharma A/S in 2015 Q1 according to their latest regulatory filings, with 36 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
36
Holders Change
+36
Holders Change %
–
% of All Funds
0.96%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.03%
New
36
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
O
OrbiMed
New York
+$26.3M
2
RCM
RA Capital Management
Massachusetts
+$18.6M
3
Fidelity Investments
Fidelity Investments
Massachusetts
+$17.8M
4
VM
VHCP Management
New York
+$14.8M
5
SAM
Sectoral Asset Management
Quebec, Canada
+$13.3M

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
O
1
OrbiMed
New York
$25.1M +$26.3M +1,448,991 New
RCM
2
RA Capital Management
Massachusetts
$17.8M +$18.6M +1,023,652 New
Fidelity Investments
3
Fidelity Investments
Massachusetts
$17M +$17.8M +981,300 New
VM
4
VHCP Management
New York
$12.9M +$14.8M +811,152 New
SAM
5
Sectoral Asset Management
Quebec, Canada
$12.7M +$13.3M +731,660 New
RIM
6
RS Investment Management
California
$11.4M +$11.9M +656,170 New
PAMU
7
Pictet Asset Management (UK)
United Kingdom
$5.94M +$6.34M +348,668 New
GPP
8
Great Point Partners
Connecticut
$5.9M +$6.18M +339,863 New
VAM
9
Visium Asset Management
New York
$4.77M +$5M +275,000 New
ACP
10
Acuta Capital Partners
California
$3.97M +$4.16M +228,612 New
Lazard Asset Management
11
Lazard Asset Management
New York
$3.55M +$3.72M +204,825 New
DM
12
Deerfield Management
New York
$3.47M +$3.64M +200,000 New
SM
13
Sabby Management
Florida
$3.37M +$3.53M +194,023 New
BA
14
BlackRock Advisors
Delaware
$2.28M +$2.39M +131,300 New
SCM
15
Scopia Capital Management
New York
$2.17M +$2.27M +125,000 New
BBA
16
Baker Bros. Advisors
New York
$1.74M +$1.82M +100,000 New
Alyeska Investment Group
17
Alyeska Investment Group
Illinois
$1.73M +$1.82M +99,955 New
DCM
18
DAFNA Capital Management
California
$1.62M +$1.7M +93,541 New
HCMT
19
Highland Capital Management (Texas)
Texas
$1.52M +$1.59M +87,609 New
SFM
20
Sphera Funds Management
Israel
$1.22M +$1.27M +70,000 New
CAM
21
Cormorant Asset Management
Massachusetts
$1.07M +$1.12M +61,500 New
Citadel Advisors
22
Citadel Advisors
Florida
$1.05M +$1.1M +60,316 New
Millennium Management
23
Millennium Management
New York
$922K +$966K +53,121 New
RSCM
24
Rock Springs Capital Management
Maryland
$617K +$646K +35,540 New
WMSA
25
Weiss Multi-Strategy Advisers
New York
$382K +$400K +22,000 New
1
2

ASND Hedge Fund Activity: Q1 2015 in Review

36 of the 3,752 institutional investors tracked by Wall St. Rank reported a position in Ascendis Pharma A/S (ASND) for Q1 2015, worth a combined $146M.

Buyers outnumbered sellers: 36 funds opened new ASND positions and 0 closed out — a net gain of 36 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was OrbiMed, opening a new position worth an estimated $26.3M.

  • 36 institutional investors held Ascendis Pharma A/S (ASND) as of Q1 2015, up from 0 in Q4 2014.
  • Funds reported $146M of Ascendis Pharma A/S stock for Q1 2015.
  • 36 funds opened new Ascendis Pharma A/S positions in Q1 2015 and 0 closed out, a net change of +36 holders.
  • The largest Ascendis Pharma A/S buyer in Q1 2015 was OrbiMed, an estimated $26.3M added.

Based on aggregated 13F filings for Q1 2015.